Impact of the gut microbiota on immune checkpoint inhibitor-associated toxicities

Immune checkpoint inhibitors (ICIs) have transformed the treatment of patients with advanced cancers. However, the majority of patients do not respond or develop early progressive disease. A substantial number also develop immune-mediated toxicities that may lead to early treatment discontinuation....

Descripción completa

Detalles Bibliográficos
Autores principales: Pezo, Rossanna C., Wong, Matthew, Martin, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747860/
https://www.ncbi.nlm.nih.gov/pubmed/31555343
http://dx.doi.org/10.1177/1756284819870911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747860/
https://www.ncbi.nlm.nih.gov/pubmed/31555343
http://dx.doi.org/10.1177/1756284819870911

Ejemplares similares